Cyclic depsipeptide compounds and their uses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9382295
SERIAL NO

14433327

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel cycloundecadepsipeptide compounds and their analoges which bind and inhibit cyclophilins, have reduced immunosuppressive activity and improved physicochemical properties including water solubility. The present invention further relates to pharmaceutical compositions containing said depsipeptide compounds and their analoges for use in the treatment or prevention of diseases and pathologies which may be ameliorated by the inhibition of cyclophilin activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CYPRALIS LIMITEDBABRAHAM HALL BABRAHAM CAMBRIDGE CB22 3AT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fliri, Hans Georg Ongar, GB 10 52
Ford, Rhonan Lee Ongar, GB 7 4
Vong, Antonio Kuok Keong Ongar, GB 11 72

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 5, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00